ABVX
Abivax S.A.
NASDAQ · Healthcare · Biotechnology · FR
$114.15
+0.10%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-93.9%
Return on equity
-65.5%
Return on assets
-65.6%
Return on invested capital
0.00x
Asset turnover
-$218.9M
Cash from operations
$7.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025